It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Gene plasticity during myogenous temporomandibular disorder (TMDM) development is largely unknown. TMDM could be modeled by intramuscular inflammation or tissue damage. To model inflammation induced TMDM we injected complete Freund’s adjuvant (CFA) into masseter muscle (MM). To model tissue damage induced TMDM we injected extracellular matrix degrading collagenase type 2 (Col). CFA and Col produced distinct myalgia development trajectories. We performed bulk RNA-seq of MM to generate gene plasticity time course. CFA initiated TMDM (1d post-injection) was mainly linked to chemo-tacticity of monocytes and neutrophils. At CFA-induced hypersensitivity post-resolution (5d post-injection), tissue repair processes were pronounced, while inflammation was absent. Col (0.2U) produced acute hypersensitivity linked to tissue repair without inflammatory processes. Col (10U) generated prolonged hypersensitivity with inflammatory processes dominating initiation phase (1d). Pre-resolution phase (6d) was accompanied with acceleration of expressions for tissue repair and pro-inflammatory genes. Flow cytometry showed that immune processes in MM was associated with accumulations of macrophages, natural killer, dendritic and T-cells, further confirming our RNA-seq findings. Altogether, CFA and Col treatments induced different immune processes in MM. Importantly, TMDM resolution was preceded with muscle cell and extracellular matrix repairs, an elevation in immune system gene expressions and distinct immune cell accumulations in MM.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 The University of Texas Health Science Center at San Antonio (UTHSCSA), Integrated Biomedical Sciences (IBMS) Program, The School of Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
2 The School of Medicine, UTHSCSA, Departments of Microbiology, Immunology & Molecular Genetics, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
3 The School of Dentistry, The University of Texas Health Science Center at San Antonio (UTHSCSA), Departments of Endodontics, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
4 The School of Medicine, UTHSCSA, Departments of Molecular Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
5 The School of Medicine, UTHSCSA, Departments of Molecular Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880); Greehey Children’s Cancer Research Institute, UTHSCSA, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
6 The University of Texas Health Science Center at San Antonio (UTHSCSA), Integrated Biomedical Sciences (IBMS) Program, The School of Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880); The School of Medicine, UTHSCSA, Departments of Microbiology, Immunology & Molecular Genetics, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)
7 The University of Texas Health Science Center at San Antonio (UTHSCSA), Integrated Biomedical Sciences (IBMS) Program, The School of Medicine, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880); The School of Dentistry, The University of Texas Health Science Center at San Antonio (UTHSCSA), Departments of Endodontics, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880)